This upregulation of the GH receptor potentiated the proliferative effects of growth hormone, as evidenced by increased cell proliferation (MTT assay) and proliferating cell nuclear antigen (PCNA) expression
Dermatology Clinics: GHK-Cu is use in advanced therapies for skin rejuvenation, such as microneedling serums, laser therapy recovery aids, and dermal boosters
Daily dose: 2,330mcg (2.33mg) total blend This breaks down to approximately: 1,700mcg (1.7mg) GHK-Cu 330mcg TB-500 330mcg BPC-157 Administration: Once daily, subcutaneous injection Cycle length: 4 weeks, followed by 2-4 week rest period Schedule: Daily injection at consistent time For a standard 70mg glow peptide vial reconstituted with 3mL bacteriostatic water, this protocol requires 0.10mL (10 units on an insulin syringe) per daily injection
After reconstitution with sterile or bacteriostatic water, store the solution at 2C to 8C and use within 30 days
BPC-157 in Inflammatory Bowel Disease (IBD) In ulcerative colitis and Crohns disease models, BPC-157 has: Reduced mucosal damage and bleeding Lowered inflammation markers Promoted rapid tissue healing Minimized recurrence of flare-ups 4